A simple and rapid protocol to non-enzymatically dissociate fresh human tissues for the analysis of infiltrating lymphocytes

Journal of Visualized Experiments

Volumn , Issue 94, 2014, Pages

  Garaud, Soizic ^a,b   Gu Trantien, Chunyan ^a,b   Lodewyckx, Jean Nicolas ^a,b   Boisson, Anaïs ^a,b   De Silva, Pushpamali ^a,b   Buisseret, Laurence ^a,b   Migliori, Edoardo ^a,b   Libin, Myriam ^a   Naveaux, Céline ^a,b   Duvillier, Hugues ^a   Willard Gallo, Karen ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

Breast cancer; CD45+; Fresh tissue homogenate; Immunology; Issue 94; Non enzymatic dissociation; Primary tissue supernatant; Tumor immunology; Tumor infiltrating lymphocytes

Indexed keywords

EID: 84917695112     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52392     Document Type: Article

References (15)

1. Chen, D. S., Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 39, (1), 1-10 (2013).
2. Boudreau, A., van’t Veer, J. L., Bissell, M. J. An ’elite hacker’: breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity. Cell Adh Migr. 6, (3), 236-248 (2012).
3. Gajewski, T. F., Schreiber, H., Fu, Y. X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 14, (10), 1014-1022 (2013).
4. Quezada, S. A., et al. Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J Exp Med. 205, (9), 2125-2138 (2008).
5. Grange, C., et al. Phenotypic characterization and functional analysis of human tumor immune infiltration after mechanical and enzymatic disaggregation. J Immunol Methods. 372, (1-2), 119-126 (2011).
6. McCauley, H. A., Guasch, G. Serial orthotopic transplantation of epithelial tumors in single-cell suspension. Methods Mol Biol. 1035, 231-245 (2013).
7. Gros, A., et al. Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. Clin Cancer Res. 18, (19), 5212-5223 (2012).
8. Zirakzadeh, A. A., Marits, P., Sherif, A., Winqvist, O. Multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies. J Immunol. 190, (11), 5847-5855 (2013).
9. Gu-Trantien, C., et al. CD4(+) follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 123, (7), 2873-2892 (2013).
10. Buisseret, L., et al. Lymphocytes Infiltrating Breast Cancer: Density, Composition And Organization. Annals of Oncology. 25, (1), 17(2014).
11. Garaud, S., et al. Characterization of B Cells Infiltrating Human Breast Cancer. Annals of Oncology. 25, (1), 18(2014).
12. Gu-Trantien, C., et al. Cxcl13-Producing Follicular Helper T Cells In Human Breast Cancer. Annals of Oncology. 25, (1), 17(2014).
13. Yee, C. The use of endogenous T cells for adoptive transfer. Immunol Rev. 257, (1), 250-263 (2014).
14. Butler, M. O., et al. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help. PLoS One. 7, (1), 30229(2012).
15. Ye, Q., et al. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes. J Transl Med. 9, 131(2011).